Key points are not available for this paper at this time.
In the past few years, we have witnessed a renaissance of the field of molecular de novo drug design. The advancements in deep learning and artificial intelligence (AI) have triggered an avalanche of ideas on how to translate such techniques to a variety of domains including the field of drug design. A range of architectures have been devised to find the optimal way of generating chemical compounds by using either graph- or string (SMILES)-based representations. With this application note, we aim to offer the community a production-ready tool for de novo design, called REINVENT. It can be effectively applied on drug discovery projects that are striving to resolve either exploration or exploitation problems while navigating the chemical space. It can facilitate the idea generation process by bringing to the researcher's attention the most promising compounds. REINVENT's code is publicly available at https://github.com/MolecularAI/Reinvent.
Building similarity graph...
Analyzing shared references across papers
Loading...
Thomas Blaschke
Josep Arús‐Pous
Hongming Chen
Journal of Chemical Information and Modeling
University of Bern
AstraZeneca (Sweden)
Guangzhou Regenerative Medicine and Health Guangdong Laboratory
Building similarity graph...
Analyzing shared references across papers
Loading...
Blaschke et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69fe09cfff03502198270ce6 — DOI: https://doi.org/10.1021/acs.jcim.0c00915